Category: Medicines and Drugs - Page 3

Bioequivalence Explained: FDA Requirements to Prove Generic Drug Equivalence
Bioequivalence Explained: FDA Requirements to Prove Generic Drug Equivalence
Learn how the FDA uses bioequivalence studies to prove generic drugs work just like brand-name versions. Understand the 80-125% rule, PK parameters, and why generics are safe and effective.
Read More
Benzodiazepines: Memory Loss, Fall Risks, and How to Taper Safely
Benzodiazepines: Memory Loss, Fall Risks, and How to Taper Safely
Benzodiazepines can cause memory loss, increase fall risk, and lead to dependence. Learn how these drugs affect the brain, why tapering slowly is critical, and what steps you can take to reduce harm.
Read More
History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
Generic drugs now make up over 90% of U.S. prescriptions, saving billions annually. This is their story - from dangerous 19th-century medicines to the Hatch-Waxman Act and modern supply chain challenges.
Read More
Medication Safety Statistics: What Patients Need to Know to Avoid Harm
Medication Safety Statistics: What Patients Need to Know to Avoid Harm
Medication errors harm over 1.5 million people yearly. Learn the most dangerous drugs, why mistakes happen, and how to protect yourself from preventable harm-backed by global statistics and real-world data.
Read More
Cost-Effectiveness Analysis: How Generic Drugs Deliver Real Value in Healthcare
Cost-Effectiveness Analysis: How Generic Drugs Deliver Real Value in Healthcare
Generic drugs save billions annually, but not all are priced fairly. Cost-effectiveness analysis reveals how to choose the most valuable options - and why some generics still cost too much.
Read More
FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained
FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained
The FDA Office of Generic Drugs ensures affordable, high-quality generic medications reach patients by reviewing applications, enforcing bioequivalence standards, and managing patent exclusivity under GDUFA and the Hatch-Waxman Act.
Read More
Clindamycin and C. difficile Risk: When to Seek Care
Clindamycin and C. difficile Risk: When to Seek Care
Clindamycin can trigger a dangerous gut infection called C. difficile. Learn the warning signs, when to seek care, and how to protect yourself from this serious antibiotic side effect.
Read More
How to Read Contraindications and Warnings on Drug Labels
How to Read Contraindications and Warnings on Drug Labels
Learn how to read contraindications and warnings on drug labels to avoid serious health risks. Understand FDA requirements, boxed warnings, and what to do when you spot a red flag.
Read More
Evergreening: How Pharmaceutical Brands Delay Generic Drugs to Protect Profits
Evergreening: How Pharmaceutical Brands Delay Generic Drugs to Protect Profits
Evergreening lets pharmaceutical companies extend drug patents with minor tweaks, blocking cheaper generics and keeping prices high. Learn how this legal strategy impacts drug access and what’s being done to stop it.
Read More
Combination Cholesterol Therapy with Reduced Statin Doses: A Smarter Way to Lower LDL
Combination Cholesterol Therapy with Reduced Statin Doses: A Smarter Way to Lower LDL
Combination cholesterol therapy with lower statin doses and non-statin drugs like ezetimibe lowers LDL more safely than high-dose statins alone. It’s now recommended for high-risk patients and works better with fewer side effects.
Read More